{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:13:34Z","timestamp":1780316014890,"version":"3.54.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kungliga Vetenskapsakademien"},{"name":"Per-Eric och Ulla Schybergs foundation"},{"name":"NIH\/NIDDK","award":["R01DK108798.AH"],"award-info":[{"award-number":["R01DK108798.AH"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinsonsfonden"},{"DOI":"10.13039\/100008738","name":"Jeanssons Stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adeno Associated Virus (AAV)-mediated gene expression in the brain is widely applied in the preclinical setting to investigate the therapeutic potential of specific molecular targets, characterize various cellular functions, and model central nervous system (CNS) diseases. In therapeutic applications in the clinical setting, gene therapy offers several advantages over traditional pharmacological based therapies, including the ability to directly manipulate disease mechanisms, selectively target disease-afflicted regions, and achieve long-term therapeutic protein expression in the absence of repeated administration of pharmacological agents. Next to the gold-standard iodixanol-based AAV vector production, we recently published a protocol for AAV production based on chloroform-precipitation, which allows for fast in-house production of small quantities of AAV vector without the need for specialized equipment. To validate our recent protocol, we present here a direct side-by-side comparison between vectors produced with either method in a series of in vitro and in vivo assays with a focus on transgene expression, cell loss, and neuroinflammatory responses in the brain. We do not find differences in transduction efficiency nor in any other parameter in our in vivo and in vitro panel of assessment. These results suggest that our novel protocol enables most standardly equipped laboratories to produce small batches of high quality and high titer AAV vectors for their experimental needs.<\/jats:p>","DOI":"10.1038\/s41598-020-78521-w","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T11:52:15Z","timestamp":1607514735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A comparison of AAV-vector production methods for gene therapy and preclinical assessment"],"prefix":"10.1038","volume":"10","author":[{"given":"Marcus","family":"Davidsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Negrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swantje","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Svanbergsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Lockowandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"78521_CR1","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/mcb.4.10.2072","volume":"4","author":"JD Tratschin","year":"1984","unstructured":"Tratschin, J. D., West, M. H., Sandbank, T. & Carter, B. J. A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol. Cell. Biol. 4, 2072\u20132081. https:\/\/doi.org\/10.1128\/mcb.4.10.2072 (1984).","journal-title":"Mol. Cell. Biol."},{"key":"78521_CR2","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.1073\/pnas.81.20.6466","volume":"81","author":"PL Hermonat","year":"1984","unstructured":"Hermonat, P. L. & Muzyczka, N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81, 6466\u20136470. https:\/\/doi.org\/10.1073\/pnas.81.20.6466 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78521_CR3","first-page":"119","volume":"99","author":"JC Grieger","year":"2005","unstructured":"Grieger, J. C. & Samulski, R. J. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv. Biochem. Eng. Biotechnol. 99, 119\u2013145 (2005).","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"78521_CR4","doi-asserted-by":"publisher","unstructured":"Gray, S. J. et al. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Curr. Protoc. Neurosci. doi:https:\/\/doi.org\/10.1002\/0471142301.ns0417s57 (2011).","DOI":"10.1002\/0471142301.ns0417s57"},{"key":"78521_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ymthe.2004.09.011","volume":"10","author":"BJ Carter","year":"2004","unstructured":"Carter, B. J. Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol. Ther. 10, 981\u2013989. https:\/\/doi.org\/10.1016\/j.ymthe.2004.09.011 (2004).","journal-title":"Mol. Ther."},{"key":"78521_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/hum.2015.025","volume":"26","author":"E Hastie","year":"2015","unstructured":"Hastie, E. & Samulski, R. J. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success\u2013a personal perspective. Hum. Gene Ther. 26, 257\u2013265. https:\/\/doi.org\/10.1089\/hum.2015.025 (2015).","journal-title":"Hum. Gene Ther."},{"key":"78521_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2016.05.027","volume":"282","author":"A Heuer","year":"2016","unstructured":"Heuer, A., Kirkeby, A., Pfisterer, U., Jonsson, M. E. & Parmar, M. hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation. Exp. Neurol. 282, 78\u201385. https:\/\/doi.org\/10.1016\/j.expneurol.2016.05.027 (2016).","journal-title":"Exp. Neurol."},{"key":"78521_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuroscience.2011.06.080","volume":"193","author":"Y Masamizu","year":"2011","unstructured":"Masamizu, Y. et al. Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Neuroscience 193, 249\u2013258. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.06.080 (2011).","journal-title":"Neuroscience"},{"key":"78521_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DG Tervo","year":"2016","unstructured":"Tervo, D. G. et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92, 372\u2013382. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.021 (2016).","journal-title":"Neuron"},{"key":"78521_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1910061116","author":"M Davidsson","year":"2019","unstructured":"Davidsson, M. et al. A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1910061116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78521_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2017.10.010","volume":"109","author":"P Aldrin-Kirk","year":"2018","unstructured":"Aldrin-Kirk, P. et al. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum. Neurobiol. Dis. 109, 148\u2013162. https:\/\/doi.org\/10.1016\/j.nbd.2017.10.010 (2018).","journal-title":"Neurobiol. Dis."},{"key":"78521_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2016.04.017","volume":"90","author":"P Aldrin-Kirk","year":"2016","unstructured":"Aldrin-Kirk, P. et al. DREADD modulation of transplanted DA neurons reveals a novel Parkinsonian Dyskinesia mechanism mediated by the serotonin 5-HT6 receptor. Neuron 90, 955\u2013968. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.017 (2016).","journal-title":"Neuron"},{"key":"78521_CR13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.cub.2011.08.028","volume":"21","author":"C Mateo","year":"2011","unstructured":"Mateo, C. et al. In vivo optogenetic stimulation of neocortical excitatory neurons drives brain-state-dependent inhibition. Curr. Biol. 21, 1593\u20131602. https:\/\/doi.org\/10.1016\/j.cub.2011.08.028 (2011).","journal-title":"Curr. Biol."},{"key":"78521_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cell.2010.02.037","volume":"141","author":"V Gradinaru","year":"2010","unstructured":"Gradinaru, V. et al. Molecular and cellular approaches for diversifying and extending optogenetics. Cell 141, 154\u2013165. https:\/\/doi.org\/10.1016\/j.cell.2010.02.037 (2010).","journal-title":"Cell"},{"key":"78521_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nn.2495","volume":"13","author":"LA Gunaydin","year":"2010","unstructured":"Gunaydin, L. A. et al. Ultrafast optogenetic control. Nat. Neurosci. 13, 387\u2013392. https:\/\/doi.org\/10.1038\/nn.2495 (2010).","journal-title":"Nat. Neurosci."},{"key":"78521_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191. https:\/\/doi.org\/10.1038\/nature14299 (2015).","journal-title":"Nature"},{"key":"78521_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech, L. et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102\u2013106. https:\/\/doi.org\/10.1038\/nbt.3055 (2015).","journal-title":"Nat. Biotechnol."},{"key":"78521_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","volume":"358","author":"DBT Cox","year":"2017","unstructured":"Cox, D. B. T. et al. RNA editing with CRISPR-Cas13. Science 358, 1019\u20131027. https:\/\/doi.org\/10.1126\/science.aaq0180 (2017).","journal-title":"Science"},{"key":"78521_CR19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/biot.201400046","volume":"9","author":"E Senis","year":"2014","unstructured":"Senis, E. et al. CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. Biotechnol. J. 9, 1402\u20131412. https:\/\/doi.org\/10.1002\/biot.201400046 (2014).","journal-title":"Biotechnol. J."},{"key":"78521_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mt.2013.285","volume":"22","author":"F Borel","year":"2014","unstructured":"Borel, F., Kay, M. A. & Mueller, C. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. Mol. Ther. 22, 692\u2013701. https:\/\/doi.org\/10.1038\/mt.2013.285 (2014).","journal-title":"Mol. Ther."},{"key":"78521_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JHD-160215","volume":"5","author":"AM Keeler","year":"2016","unstructured":"Keeler, A. M. et al. Cellular analysis of silencing the Huntington\u2019s disease gene using AAV9 mediated delivery of artificial micro RNA into the striatum of Q140\/Q140 mice. J. Huntingtons Dis. 5, 239\u2013248. https:\/\/doi.org\/10.3233\/JHD-160215 (2016).","journal-title":"J. Huntingtons Dis."},{"key":"78521_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/hum.2017.199","volume":"29","author":"EL Pfister","year":"2018","unstructured":"Pfister, E. L. et al. Artificial miRNAs reduce human mutant Huntingtin throughout the striatum in a transgenic sheep model of Huntington\u2019s disease. Hum. Gene Ther. 29, 663\u2013673. https:\/\/doi.org\/10.1089\/hum.2017.199 (2018).","journal-title":"Hum. Gene Ther."},{"key":"78521_CR23","doi-asserted-by":"publisher","unstructured":"Thakore, P. I. et al. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors. Nat Commun 9, 1674. doi:https:\/\/doi.org\/10.1038\/s41467-018-04048-4 (2018).","DOI":"10.1038\/s41467-018-04048-4"},{"key":"78521_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature24049","volume":"550","author":"OO Abudayyeh","year":"2017","unstructured":"Abudayyeh, O. O. et al. RNA targeting with CRISPR-Cas13. Nature 550, 280\u2013284. https:\/\/doi.org\/10.1038\/nature24049 (2017).","journal-title":"Nature"},{"key":"78521_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison, R. W., Casto, B. C. & Hammon, W. M. Adenovirus-associated defective virus particles. Science 149, 754\u2013756. https:\/\/doi.org\/10.1126\/science.149.3685.754 (1965).","journal-title":"Science"},{"key":"78521_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay, S. et al. An essential receptor for adeno-associated virus infection. Nature 530, 108\u2013112. https:\/\/doi.org\/10.1038\/nature16465 (2016).","journal-title":"Nature"},{"key":"78521_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1128\/jvi.45.2.555-564.1983","volume":"45","author":"A Srivastava","year":"1983","unstructured":"Srivastava, A., Lusby, E. W. & Berns, K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555\u2013564 (1983).","journal-title":"J. Virol."},{"key":"78521_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/brain\/awaa020","volume":"143","author":"Y Chu","year":"2020","unstructured":"Chu, Y., Bartus, R. T., Manfredsson, F. P., Olanow, C. W. & Kordower, J. H. Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson\u2019s disease. Brain 143, 960\u2013975. https:\/\/doi.org\/10.1093\/brain\/awaa020 (2020).","journal-title":"Brain"},{"key":"78521_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4155\/tde.10.50","volume":"1","author":"SJ Gray","year":"2010","unstructured":"Gray, S. J., Woodard, K. T. & Samulski, R. J. Viral vectors and delivery strategies for CNS gene therapy. Ther. Deliv. 1, 517\u2013534. https:\/\/doi.org\/10.4155\/tde.10.50 (2010).","journal-title":"Ther. Deliv."},{"key":"78521_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.2006.17.1","volume":"17","author":"LF Wong","year":"2006","unstructured":"Wong, L. F. et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum. Gene Ther. 17, 1\u20139. https:\/\/doi.org\/10.1089\/hum.2006.17.1 (2006).","journal-title":"Hum. Gene Ther."},{"key":"78521_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.virol.2007.10.007","volume":"372","author":"DB Howard","year":"2008","unstructured":"Howard, D. B., Powers, K., Wang, Y. & Harvey, B. K. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372, 24\u201334. https:\/\/doi.org\/10.1016\/j.virol.2007.10.007 (2008).","journal-title":"Virology"},{"key":"78521_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/hum.2006.178","volume":"18","author":"JM Taymans","year":"2007","unstructured":"Taymans, J. M. et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum. Gene Ther. 18, 195\u2013206. https:\/\/doi.org\/10.1089\/hum.2006.178 (2007).","journal-title":"Hum. Gene Ther."},{"key":"78521_CR33","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty, D. M., Monahan, P. E. & Samulski, R. J. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248\u20131254. https:\/\/doi.org\/10.1038\/sj.gt.3301514 (2001).","journal-title":"Gene Ther."},{"key":"78521_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209. https:\/\/doi.org\/10.1038\/nbt.3440 (2016).","journal-title":"Nat. Biotechnol."},{"key":"78521_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179. https:\/\/doi.org\/10.1038\/nn.4593 (2017).","journal-title":"Nat. Neurosci."},{"key":"78521_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2016.11.045","volume":"93","author":"B Zingg","year":"2017","unstructured":"Zingg, B. et al. AAV-mediated anterograde transsynaptic tagging: mapping corticocollicular input-defined neural pathways for defense behaviors. Neuron 93, 33\u201347. https:\/\/doi.org\/10.1016\/j.neuron.2016.11.045 (2017).","journal-title":"Neuron"},{"key":"78521_CR37","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ymthe.2020.02.009","volume":"28","author":"K Borner","year":"2020","unstructured":"Borner, K. et al. Pre-arrayed Pan-AAV peptide display libraries for rapid single-round screening. Mol. Ther. 28, 1016\u20131032. https:\/\/doi.org\/10.1016\/j.ymthe.2020.02.009 (2020).","journal-title":"Mol. Ther."},{"key":"78521_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.omtn.2017.06.011","volume":"8","author":"NM Kanaan","year":"2017","unstructured":"Kanaan, N. M. et al. Rationally engineered AAV capsids improve transduction and volumetric spread in the CNS. Mol. Ther. Nucleic Acids 8, 184\u2013197. https:\/\/doi.org\/10.1016\/j.omtn.2017.06.011 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"78521_CR39","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/sj.gt.3302150","volume":"10","author":"HB Gaspar","year":"2003","unstructured":"Gaspar, H. B., Howe, S. & Thrasher, A. J. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency. Gene Ther. 10, 1999\u20132004. https:\/\/doi.org\/10.1038\/sj.gt.3302150 (2003).","journal-title":"Gene Ther."},{"key":"78521_CR40","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","volume":"372","author":"SG Jacobson","year":"2015","unstructured":"Jacobson, S. G. et al. Improvement and decline in vision with gene therapy in childhood blindness. N. Engl. J. Med. 372, 1920\u20131926. https:\/\/doi.org\/10.1056\/NEJMoa1412965 (2015).","journal-title":"N. Engl. J. Med."},{"key":"78521_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.gt.3302039","volume":"10","author":"JY Sun","year":"2003","unstructured":"Sun, J. Y., Anand-Jawa, V., Chatterjee, S. & Wong, K. K. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther. 10, 964\u2013976. https:\/\/doi.org\/10.1038\/sj.gt.3302039 (2003).","journal-title":"Gene Ther."},{"key":"78521_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/21678707.2015.1039511","volume":"3","author":"E Hastie","year":"2015","unstructured":"Hastie, E. & Samulski, R. J. Recombinant adeno-associated virus vectors in the treatment of rare diseases. Expert Opin. Orphan Drugs 3, 675\u2013689. https:\/\/doi.org\/10.1517\/21678707.2015.1039511 (2015).","journal-title":"Expert Opin. Orphan Drugs"},{"key":"78521_CR43","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1002\/jgm.3015","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M. & Abedi, M. R. Gene therapy clinical trials worldwide to 2017: an update. J. Gene Med. 20, e3015. https:\/\/doi.org\/10.1002\/jgm.3015 (2018).","journal-title":"J. Gene Med."},{"key":"78521_CR44","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/gt.2008.68","volume":"15","author":"C Mueller","year":"2008","unstructured":"Mueller, C. & Flotte, T. R. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858\u2013863. https:\/\/doi.org\/10.1038\/gt.2008.68 (2008).","journal-title":"Gene Ther."},{"key":"78521_CR45","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire, A. M. et al. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N. Engl. J. Med. 358, 2240\u20132248. https:\/\/doi.org\/10.1056\/NEJMoa0802315 (2008).","journal-title":"N. Engl. J. Med."},{"key":"78521_CR46","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","volume":"126","author":"AM Maguire","year":"2019","unstructured":"Maguire, A. M. et al. Efficacy, safety, and durability of voretigene Neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology 126, 1273\u20131285. https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.017 (2019).","journal-title":"Ophthalmology"},{"key":"78521_CR47","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell, S. et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390, 849\u2013860. https:\/\/doi.org\/10.1016\/S0140-6736(17)31868-8 (2017).","journal-title":"Lancet"},{"key":"78521_CR48","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1093\/hmg\/ddz157","volume":"28","author":"P Batty","year":"2019","unstructured":"Batty, P. & Lillicrap, D. Advances and challenges for hemophilia gene therapy. Hum. Mol. Genet. 28, R95\u2013R101. https:\/\/doi.org\/10.1093\/hmg\/ddz157 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"78521_CR49","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa1706198 (2017).","journal-title":"N. Engl. J. Med."},{"key":"78521_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/hum.2016.087","volume":"27","author":"M Hocquemiller","year":"2016","unstructured":"Hocquemiller, M., Giersch, L., Audrain, M., Parker, S. & Cartier, N. Adeno-associated virus-based gene therapy for CNS diseases. Hum. Gene Ther. 27, 478\u2013496. https:\/\/doi.org\/10.1089\/hum.2016.087 (2016).","journal-title":"Hum. Gene Ther."},{"key":"78521_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/cpns.103","author":"M Negrini","year":"2020","unstructured":"Negrini, M., Wang, G., Heuer, A., Bjorklund, T. & Davidsson, M. AAV production everywhere: a simple, fast, and reliable protocol for inhouse AAV vector production based on chloroform extraction. Curr. Prot. Neurosci. https:\/\/doi.org\/10.1002\/cpns.103 (2020).","journal-title":"Curr. Prot. Neurosci."},{"key":"78521_CR52","first-page":"485","volume":"46","author":"W Xiaobing","year":"2001","unstructured":"Xiaobing, W. et al. A novel method for purification of recombinant adeno-associated virus vectors on a large scale. Chin. Sci. Bull. 46, 485\u2013488 (2001).","journal-title":"Chin. Sci. Bull."},{"key":"78521_CR53","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/978-1-4939-9065-8_6","volume":"101\u2013124","author":"IM Sandoval","year":"1937","unstructured":"Sandoval, I. M., Kuhn, N. M. & Manfredsson, F. P. Multimodal production of adeno-associated virus. Methods Mol. Biol. 101\u2013124, 2019. https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_6 (1937).","journal-title":"Methods Mol. Biol."},{"key":"78521_CR54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973\u2013985. https:\/\/doi.org\/10.1038\/sj.gt.3300938 (1999).","journal-title":"Gene Ther."},{"key":"78521_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/hgtb.2015.117","volume":"27","author":"MJ Benskey","year":"2016","unstructured":"Benskey, M. J., Sandoval, I. M. & Manfredsson, F. P. Continuous collection of adeno-associated virus from producer cell medium significantly increases total viral yield. Hum. Gene Ther. Methods 27, 32\u201345. https:\/\/doi.org\/10.1089\/hgtb.2015.117 (2016).","journal-title":"Hum. Gene Ther. Methods"},{"key":"78521_CR56","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson, B. J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604\u20138610. https:\/\/doi.org\/10.1021\/ac202028g (2011).","journal-title":"Anal. Chem."},{"key":"78521_CR57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.expneurol.2013.01.020","volume":"247","author":"A Heuer","year":"2013","unstructured":"Heuer, A., Lelos, M. J., Kelly, C. M., Torres, E. M. & Dunnett, S. B. Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats. Exp. Neurol. 247, 485\u2013495. https:\/\/doi.org\/10.1016\/j.expneurol.2013.01.020 (2013).","journal-title":"Exp. Neurol."},{"key":"78521_CR58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.euroneuro.2006.04.009","volume":"17","author":"EM Torres","year":"2007","unstructured":"Torres, E. M. & Dunnett, S. B. Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson\u2019s disease. Eur. Neuropsychopharmacol. 17, 206\u2013214. https:\/\/doi.org\/10.1016\/j.euroneuro.2006.04.009 (2007).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"78521_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt, U. & Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485\u2013493. https:\/\/doi.org\/10.1016\/0006-8993(70)90187-3 (1970).","journal-title":"Brain Res."},{"key":"78521_CR60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0006-8993(69)90122-x","volume":"14","author":"U Ungerstedt","year":"1969","unstructured":"Ungerstedt, U., Butcher, L. L., Butcher, S. G., Anden, N. E. & Fuxe, K. Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461\u2013471. https:\/\/doi.org\/10.1016\/0006-8993(69)90122-x (1969).","journal-title":"Brain Res."},{"key":"78521_CR61","doi-asserted-by":"publisher","first-page":"108542","DOI":"10.1016\/j.jneumeth.2019.108542","volume":"336","author":"M Lockowandt","year":"2020","unstructured":"Lockowandt, M. et al. Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector. J. Neurosci. Methods 336, 108542. https:\/\/doi.org\/10.1016\/j.jneumeth.2019.108542 (2020).","journal-title":"J. Neurosci. Methods"},{"key":"78521_CR62","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/ejn.12036","volume":"37","author":"A Heuer","year":"2013","unstructured":"Heuer, A., Smith, G. A. & Dunnett, S. B. Comparison of 6-hydroxydopamine lesions of the substantia nigra and the medial forebrain bundle on a lateralised choice reaction time task in mice. Eur. J. Neurosci. 37, 294\u2013302. https:\/\/doi.org\/10.1111\/ejn.12036 (2013).","journal-title":"Eur. J. Neurosci."},{"key":"78521_CR63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1128\/JVI.25.1.331-338.1978","volume":"25","author":"RM Buller","year":"1978","unstructured":"Buller, R. M. & Rose, J. A. Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J. Virol. 25, 331\u2013338. https:\/\/doi.org\/10.1128\/JVI.25.1.331-338.1978 (1978).","journal-title":"J. Virol."},{"key":"78521_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-181525","volume":"9","author":"A Bjorklund","year":"2019","unstructured":"Bjorklund, A. & Dunnett, S. B. The amphetamine induced rotation test: a re-assessment of its use as a tool to monitor motor impairment and functional recovery in rodent models of Parkinson\u2019s disease. J.Parkinsons Dis. 9, 17\u201329. https:\/\/doi.org\/10.3233\/JPD-181525 (2019).","journal-title":"J.Parkinsons Dis."},{"key":"78521_CR65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","volume":"17","author":"S Nayak","year":"2010","unstructured":"Nayak, S. & Herzog, R. W. Progress and prospects: immune responses to viral vectors. Gene Ther. 17, 295\u2013304. https:\/\/doi.org\/10.1038\/gt.2009.148 (2010).","journal-title":"Gene Ther."},{"key":"78521_CR66","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/mt.2009.130","volume":"17","author":"MO Lasaro","year":"2009","unstructured":"Lasaro, M. O. & Ertl, H. C. New insights on adenovirus as vaccine vectors. Mol. Ther. 17, 1333\u20131339. https:\/\/doi.org\/10.1038\/mt.2009.130 (2009).","journal-title":"Mol. Ther."},{"key":"78521_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v11020102","volume":"11","author":"J Rabinowitz","year":"2019","unstructured":"Rabinowitz, J., Chan, Y. K. & Samulski, R. J. Adeno-associated virus (AAV) versus immune response. Viruses 11, 1. https:\/\/doi.org\/10.3390\/v11020102 (2019).","journal-title":"Viruses"},{"key":"78521_CR68","unstructured":"Vance, M. A., Mitchell, A. & Samulski, R. J. in Gene therapy\u2014principles and challenges (ed Doaa Hashad) (Intech, 2015)."},{"key":"78521_CR69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ymthe.2017.09.006","volume":"26","author":"DS Ojala","year":"2018","unstructured":"Ojala, D. S. et al. In vivo selection of a computationally designed SCHEMA AAV library yields a novel variant for infection of adult neural stem cells in the SVZ. Mol. Ther. 26, 304\u2013319. https:\/\/doi.org\/10.1016\/j.ymthe.2017.09.006 (2018).","journal-title":"Mol. Ther."},{"key":"78521_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-10-74","volume":"10","author":"BL Ellis","year":"2013","unstructured":"Ellis, B. L. et al. A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype. Virol. J. 10, 74. https:\/\/doi.org\/10.1186\/1743-422X-10-74 (2013).","journal-title":"Virol. J."},{"key":"78521_CR71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/exnr.1998.6848","volume":"152","author":"D Kirik","year":"1998","unstructured":"Kirik, D., Rosenblad, C. & Bjorklund, A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152, 259\u2013277. https:\/\/doi.org\/10.1006\/exnr.1998.6848 (1998).","journal-title":"Exp. Neurol."},{"key":"78521_CR72","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ejn.13493","volume":"45","author":"N Landeck","year":"2017","unstructured":"Landeck, N., Buck, K. & Kirik, D. Toxic effects of human and rodent variants of alpha-synuclein in vivo. Eur. J. Neurosci. 45, 536\u2013547. https:\/\/doi.org\/10.1111\/ejn.13493 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"78521_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F. & High, K. A. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122, 23\u201336. https:\/\/doi.org\/10.1182\/blood-2013-01-306647 (2013).","journal-title":"Blood"},{"key":"78521_CR74","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D. A. & Mingozzi, F. Human immune responses to adeno-associated virus (AAV) vectors. Front. Immunol. 11, 670. https:\/\/doi.org\/10.3389\/fimmu.2020.00670 (2020).","journal-title":"Front. Immunol."},{"key":"78521_CR75","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fnmol.2020.00168","volume":"13","author":"V Di Maria","year":"2020","unstructured":"Di Maria, V. et al. Development and validation of CRISPR activator systems for overexpression of CB1 receptors in neurons. Front. Mol. Neurosci. 13, 168. https:\/\/doi.org\/10.3389\/fnmol.2020.00168 (2020).","journal-title":"Front. Mol. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78521-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:37:49Z","timestamp":1670373469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78521-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78521"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78521-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The version of this Article previously published contained lower resolution images for Figures 1, 2, 3 and 4. This has now been corrected in the PDF and HTML versions of the Article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21532"}}